ADAR1 Capital Management logo

ADAR1 Capital Management

Description

ADAR1 Capital Management is an investment firm.

Investor Profile

ADAR1 Capital Management has backed more than 10 startups, with 8 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 6 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity, Series C, Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.

Stage Focus

  • Post Ipo Equity (80%)
  • Series C (10%)
  • Series A (10%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Life Science
  • Medical
  • Pharmaceutical
  • Genetics
  • Robotics
  • Health Diagnostics
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ADAR1 Capital Management frequently co-invest with?

BP
North America, California, United States, San Francisco
Co-Investments: 1
Nantahala Capital Management
North America, Connecticut, United States, New Canaan
Co-Investments: 3
Venrock Healthcare Capital Partners
North America, California, United States, Palo Alto
Co-Investments: 1
Co-Investments: 1
Frazier Life Sciences
North America, California, United States, Menlo Park
Co-Investments: 2
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
VC
North America, Georgia, United States, Alpharetta
Co-Investments: 1
SC
North America, Oregon, United States, Bend
Co-Investments: 2
Co-Investments: 2
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 4

What are some of recent deals done by ADAR1 Capital Management?

Athira Pharma

Seattle, Washington, United States

Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.

BiotechnologyPharmaceuticalTherapeutics
Post Ipo EquityDec 18, 2025
Amount Raised: $90,000,000
Kalaris Therapeutics

Houston, Texas, United States

Kalaris Therapeutics is a biopharmaceutical company that provides development and commercialization of treatments for retinal diseases.

BiotechnologyClinical TrialsPharmaceutical
Post Ipo EquityDec 17, 2025
Amount Raised: $50,000,000
Crescent Biopharma

Rockville, Maryland, United States

Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.

BiotechnologyHealth CareMedical Device
Post Ipo EquityDec 4, 2025
Amount Raised: $185,000,000
Kazia Therapeutics

Hornsby, New South Wales, Australia

Kazia Therapeutics is an oncology focused biotechnology company.

BiotechnologyClinical TrialsCommercialInnovation ManagementOncologyPharmaceutical
Post Ipo EquityDec 2, 2025
Amount Raised: $32,874,190
Bambusa Therapeutics

Boston, Massachusetts, United States

Bambusa Therapeutics operates as biotechnology company.

BiotechnologyHealth CareLife ScienceMedical
Series ANov 17, 2025
atai Life Sciences

Munich, Bayern, Germany

Atai Life Sciences develops innovative mental health treatments that address significant unmet medical needs.

BiotechnologyLife ScienceMental HealthNeuroscienceTherapeutics
Post Ipo EquityOct 16, 2025
Amount Raised: $149,500,000
Quoin Pharmaceuticals

Ashburn, Virginia, United States

Quoin Pharmaceuticals is into developing products which address major unmet medical needs.

BiotechnologyMedicalPharmaceutical
Post Ipo EquityOct 10, 2025
Amount Raised: $104,500,000
Ovid Therapeutics

New York, New York, United States

Ovid Therapeutic's purpose is to solve intractable medical problems.

BiopharmaBiotechnologyHealth Care
Post Ipo EquityOct 3, 2025
Amount Raised: $81,000,000
Palisade Bio

Carlsbad, California, United States

Palisade Bio is a clinical-stage biopharmaceutical company that develops therapies for acute and chronic gastrointestinal complications.

BiopharmaBiotechnologyHealth CareTherapeutics
Post Ipo EquityOct 1, 2025
Amount Raised: $138,000,000
Aquestive Therapeutics

Warren, New Jersey, United States

Aquestive is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems.

Pharmaceutical
Post Ipo EquityAug 14, 2025
Amount Raised: $85,000,000

Find More Investors Like ADAR1 Capital Management

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

ADAR1 Capital Management | Pipeseed